The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 14, 2021

Filed:

Apr. 14, 2017
Applicant:

The Trustees of the University of Pennsylvania, Philadelphia, PA (US);

Inventors:

Anna P. Tretiakova, Woburn, MA (US);

James M. Wilson, Philadelphia, PA (US);

Assignee:
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 48/00 (2006.01); A61K 35/761 (2015.01); A61K 9/00 (2006.01); A61K 9/10 (2006.01); C07K 16/22 (2006.01); C12N 15/86 (2006.01);
U.S. Cl.
CPC ...
A61K 48/0075 (2013.01); A61K 9/0019 (2013.01); A61K 9/0048 (2013.01); A61K 9/10 (2013.01); A61K 35/761 (2013.01); A61K 48/005 (2013.01); C07K 16/22 (2013.01); C12N 15/86 (2013.01); C07K 2317/55 (2013.01); C07K 2319/33 (2013.01); C12N 2750/14143 (2013.01);
Abstract

A recombinant adeno-associated virus (rAAV) having an AAV8 capsid which is suitable for intra-retinal injection is provided herein. The rAAV comprises a vector genome packaged within the capsid which contains, operably linked to regulatory elements which direct expression of anti-human vascular endothelial growth factor (VEGF) antigen binding antibody fragment (aVEGF), a coding sequence for aVEGF, wherein the coding sequence is operably linked to regulatory elements which direct expression of the anti-VEGF Fab in the eye. Also provided herein are liquid suspensions containing these rAAV8.aVEGF and methods of using same for treatment of wet AMD and other ocular conditions.


Find Patent Forward Citations

Loading…